Latest Insider Transactions at Delcath Systems, Inc. (DCTH)
This section provides a real-time view of insider transactions for Delcath Systems, Inc. (DCTH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of DELCATH SYSTEMS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of DELCATH SYSTEMS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 22
2024
|
Gerard J Michel CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+4.96%
|
$99,996
$6.0 P/Share
|
|
Apr 18
2024
|
Gil Aharon Director |
BUY
Conversion of derivative security
|
Indirect |
991,615
+27.0%
|
-
|
|
Apr 18
2024
|
Gil Aharon Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
619,946
+18.78%
|
$3,843,045,254
$6199.46 P/Share
|
|
Apr 18
2024
|
Steven A J Salamon Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
619,946
+18.49%
|
$3,843,045,254
$6199.46 P/Share
|
|
Apr 18
2024
|
Steven A J Salamon Director |
BUY
Conversion of derivative security
|
Indirect |
991,615
+26.63%
|
-
|
|
Apr 18
2024
|
Rosalind Advisors, Inc. Director |
BUY
Conversion of derivative security
|
Indirect |
991,615
+26.41%
|
-
|
|
Apr 18
2024
|
Rosalind Advisors, Inc. Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
619,946
+18.32%
|
$3,843,045,254
$6199.46 P/Share
|
|
Mar 19
2024
|
Gil Aharon Director |
BUY
Open market or private purchase
|
Direct |
26,882
+2.45%
|
$80,646
$3.72 P/Share
|
|
Mar 19
2024
|
Steven A J Salamon Director |
BUY
Open market or private purchase
|
Direct |
26,882
+2.34%
|
$80,646
$3.72 P/Share
|
|
Mar 19
2024
|
Sandra Pennell SVP OF FINANCE, PFO AND PAO |
BUY
Grant, award, or other acquisition
|
Direct |
26,881
+30.57%
|
$80,643
$3.72 P/Share
|
|
Mar 19
2024
|
Gerard J Michel CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
40,323
+11.76%
|
$120,969
$3.72 P/Share
|
|
Mar 19
2024
|
Vojo Vukovic CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
26,882
+17.48%
|
$80,646
$3.72 P/Share
|
|
Mar 19
2024
|
David L. Hoffman GEN'L COUNSEL, CCO & SECY |
BUY
Grant, award, or other acquisition
|
Direct |
20,161
+21.34%
|
$60,483
$3.72 P/Share
|
|
Mar 19
2024
|
Kevin Muir GM INTERVENTIONAL ONCOLOGY |
BUY
Grant, award, or other acquisition
|
Direct |
13,441
+41.97%
|
$40,323
$3.72 P/Share
|
|
Dec 12
2023
|
Vojo Vukovic CHIEF MEDICAL OFFICER |
BUY
Open market or private purchase
|
Direct |
40,000
+28.57%
|
$120,000
$3.0 P/Share
|
|
Dec 08
2023
|
Gerard J Michel CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
34,000
+11.47%
|
$68,000
$2.94 P/Share
|
|
Nov 17
2023
|
Rosalind Advisors, Inc. Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+8.78%
|
$200,000
$2.4 P/Share
|
|
Nov 17
2023
|
Sandra Pennell SVP OF FINANCE, PFO AND PAO |
BUY
Open market or private purchase
|
Direct |
30,000
+50.0%
|
$60,000
$2.43 P/Share
|
|
Nov 16
2023
|
David L. Hoffman GEN'L COUNSEL, CCO & SECY |
BUY
Open market or private purchase
|
Direct |
40,000
+50.0%
|
$80,000
$2.48 P/Share
|
|
Nov 16
2023
|
Vojo Vukovic CHIEF MEDICAL OFFICER |
BUY
Open market or private purchase
|
Direct |
60,000
+50.0%
|
$120,000
$2.48 P/Share
|
|
Oct 13
2023
|
John Purpura CHIEF OPERATING OFFICER |
BUY
Open market or private purchase
|
Direct |
14,505
+25.89%
|
$43,515
$3.44 P/Share
|
|
Aug 21
2023
|
John Richard Sylvester |
BUY
Open market or private purchase
|
Direct |
10,550
+50.0%
|
$42,200
$4.8 P/Share
|
|
Aug 18
2023
|
Gerard J Michel CHIEF EXECUTIVE OFFICER |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
31,110
+11.99%
|
$124,440
$4.5 P/Share
|
|
Mar 29
2023
|
Gerard J Michel CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
19,646
+9.06%
|
$78,584
$4.84 P/Share
|
|
Dec 14
2022
|
Rosalind Advisors, Inc. Director |
BUY
Open market or private purchase
|
Indirect |
15,215
+3.21%
|
$45,645
$3.62 P/Share
|
|
Dec 14
2022
|
Steven A J Salamon Director |
BUY
Open market or private purchase
|
Direct |
15,215
+3.23%
|
$45,645
$3.62 P/Share
|
|
Dec 13
2022
|
Gerard J Michel CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
51,725
+22.56%
|
$103,450
$2.9 P/Share
|
|
Jul 20
2022
|
Gerard J Michel CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
62,814
+33.29%
|
$188,442
$3.98 P/Share
|
|
May 16
2022
|
John Purpura CHIEF OPERATING OFFICER |
BUY
Open market or private purchase
|
Direct |
3,300
+10.88%
|
$13,200
$4.61 P/Share
|
|
May 13
2022
|
Steven A J Salamon Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+1.12%
|
$25,000
$5.03 P/Share
|
|
May 12
2022
|
Steven A J Salamon Director |
BUY
Open market or private purchase
|
Indirect |
6,000
+16.94%
|
$24,000
$4.9 P/Share
|
|
Apr 19
2022
|
Rosalind Advisors, Inc. Director |
BUY
Open market or private purchase
|
Indirect |
1,600
+0.37%
|
$9,600
$6.25 P/Share
|
|
Apr 19
2022
|
Steven A J Salamon Director |
BUY
Open market or private purchase
|
Indirect |
1,600
+0.37%
|
$9,600
$6.25 P/Share
|
|
Apr 18
2022
|
Gil Aharon Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+0.49%
|
$12,000
$6.35 P/Share
|
|
Apr 18
2022
|
Rosalind Advisors, Inc. Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+0.46%
|
$12,000
$6.35 P/Share
|
|
Apr 18
2022
|
Gerard J Michel CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
2,000
+1.55%
|
$12,000
$6.36 P/Share
|
|
Apr 13
2022
|
Steven A J Salamon Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+0.35%
|
$9,000
$6.45 P/Share
|
|
Apr 13
2022
|
Rosalind Advisors, Inc. Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+0.35%
|
$9,000
$6.45 P/Share
|
|
Apr 12
2022
|
Steven A J Salamon Director |
BUY
Open market or private purchase
|
Indirect |
2,500
+0.58%
|
$15,000
$6.48 P/Share
|
|
Apr 12
2022
|
Rosalind Advisors, Inc. Director |
BUY
Open market or private purchase
|
Indirect |
2,500
+0.58%
|
$15,000
$6.48 P/Share
|
|
Apr 11
2022
|
John Purpura CHIEF OPERATING OFFICER |
BUY
Open market or private purchase
|
Direct |
5,000
+17.41%
|
$30,000
$6.59 P/Share
|
|
Apr 08
2022
|
Gerard J Michel CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
2,000
+1.62%
|
$12,000
$6.57 P/Share
|
|
Apr 07
2022
|
Rosalind Advisors, Inc. Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.23%
|
$6,000
$6.41 P/Share
|
|
Apr 07
2022
|
Steven A J Salamon Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.24%
|
$6,000
$6.41 P/Share
|
|
Apr 06
2022
|
Rosalind Advisors, Inc. Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.24%
|
$6,000
$6.49 P/Share
|
|
Apr 06
2022
|
Steven A J Salamon Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.24%
|
$6,000
$6.49 P/Share
|
|
Dec 30
2021
|
Rosalind Advisors, Inc. Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+0.47%
|
$14,000
$7.56 P/Share
|
|
Dec 30
2021
|
Steven A J Salamon Director |
BUY
Open market or private purchase
|
Direct |
2,000
+0.47%
|
$14,000
$7.56 P/Share
|
|
Dec 02
2021
|
Gerard J Michel CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
23,200
+28.21%
|
$185,600
$8.61 P/Share
|
|
Jun 30
2021
|
Rosalind Advisors, Inc. Director |
BUY
Open market or private purchase
|
Indirect |
5,500
+1.29%
|
$66,000
$12.76 P/Share
|